Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v8-EN | Version v4-FR | |
|---|---|---|
| Language | English | French |
| Date Updated | 2023-02-02 | 2022-12-06 |
| Drug Identification Number | 02473887 | 02473887 |
| Brand name | GLYCOPYRROLATE INJECTION USP | GLYCOPYRROLATE INJECTION USP |
| Common or Proper name | GLYCOPYRROLATE INJECTION USP | GLYCOPYRROLATE INJECTION USP |
| Company Name | STERIMAX INC | STERIMAX INC |
| Ingredients | GLYCOPYRROLATE | GLYCOPYRROLATE |
| Strength(s) | 4MG | 4MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR | INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 1 vial 20 ml | 1 vial 20 ml |
| ATC code | A03AB | A03AB |
| ATC description | DRUGS FOR FUNCTIONAL BOWEL DISORDERS | DRUGS FOR FUNCTIONAL BOWEL DISORDERS |
| Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
| Anticipated start date | ||
| Actual start date | 2022-12-01 | 2022-12-01 |
| Estimated end date | 2023-02-06 | 2023-02-06 |
| Actual end date | 2023-02-01 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Product is available at McKesson. | Product is available at McKesson. |
| Health Canada comments |